Saad Mark E (CIK 0001295913)

Latest company ownership

PSTV - PLUS THERAPEUTICS, INC.

Role: CFO

Shares held

138,430

Last filed at

Apr 15, 2014

Confidence Score

50.0

2025Q4

Confidence Score History

2010Q2 2025Q4

AXSM - Axsome Therapeutics, Inc.

Role: Director

Shares held

100

Last filed at

Nov 19, 2021

Confidence Score

42.2

2025Q4

Confidence Score History

2019Q2 2025Q4

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Sep 5, 2025	Sep 5, 2025	Axsome Therapeutics, Inc.	Director	Sell	5.0	-9,127	-46.98%	✓	$1.1M
Sep 11, 2024	Sep 11, 2024	Axsome Therapeutics, Inc.	Director	Sell	5.0	-11,016	-51.67%	✓	$1M
Nov 17, 2021	Nov 19, 2021	Axsome Therapeutics, Inc.	Director	Buy	95.0	+3,300	47.13%	✗	$113.9K
May 23, 2019	May 24, 2019	Axsome Therapeutics, Inc.	Director	Buy	95.0	+3,500	99.94%	✗	$78.2K
Mar 14, 2012	Mar 14, 2012	PLUS THERAPEUTICS, INC.	CFO	Buy	86.3	+10,000	7.02%	✗	$25.5K
Aug 12, 2011	Aug 12, 2011	PLUS THERAPEUTICS, INC.	CFO	Buy	86.3	+6,500	5.60%	✗	$20.3K
May 21, 2010	May 21, 2010	PLUS THERAPEUTICS, INC.	CFO	Buy	86.3	+6,000	7.84%	✗	$25.7K